Rmr Wealth Builders Bristol Myers Squibb CO Transaction History

Rmr Wealth Builders

$939 Million
Q3 2024

A detailed history of Rmr Wealth Builders transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Rmr Wealth Builders holds 5,648 shares of BMY stock, worth $332,497. This represents 0.03% of its overall portfolio holdings.

Number of Shares

5,648

Previous 5,756 1.88%

Holding current value

$332,497

Previous $239,000 22.18%

% of portfolio

0.03%

Previous 0.03%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 21, 2024	SELL	$39.66 - $51.75 $4,283 - $5,589	-108 Reduced 1.88%	5,648 $292,000
Q2 2024 Jul 23, 2024	SELL	$40.25 - $52.99 $1,972 - $2,596	-49 Reduced 0.84%	5,756 $239,000
Q1 2024 Apr 15, 2024	BUY	$47.98 - $54.4 $24,805 - $28,124	517 Added 9.78%	5,805 $314,000
Q4 2023 Feb 06, 2024	SELL	$48.48 - $57.85 $7,368 - $8,793	-152 Reduced 2.79%	5,288 $271,000
Q3 2023 Oct 23, 2023	SELL	$57.89 - $64.73 $6,310 - $7,055	-109 Reduced 1.96%	5,440 $315,000
Q2 2023 Jul 21, 2023	BUY	$63.71 - $70.74 $1,783 - $1,980	28 Added 0.51%	5,549 $354,000
Q1 2023 Apr 11, 2023	SELL	$65.71 - $74.53 $19,187 - $21,762	-292 Reduced 5.02%	5,521 $382,000
Q4 2022 Feb 15, 2023	BUY	$68.48 - $81.09 $398,074 - $471,376	5,813 New	5,813 $418,000
Q3 2022 Nov 08, 2022	BUY	$0.13 - $76.84 $3 - $1,997	26 Added 0.45%	5,803 $413,000
Q2 2022 Aug 02, 2022	SELL	$72.62 - $79.98 $63,106 - $69,502	-869 Reduced 13.08%	5,777 $445,000
Q1 2022 May 13, 2022	BUY	$61.48 - $73.72 $14,632 - $17,545	238 Added 3.71%	6,646 $485,000
Q4 2021 Feb 02, 2022	BUY	$53.63 - $62.52 $12,763 - $14,879	238 Added 3.86%	6,408 $400,000
Q3 2021 Oct 18, 2021	BUY	$59.17 - $69.31 $21,064 - $24,674	356 Added 6.12%	6,170 $365,000
Q2 2021 Aug 16, 2021	SELL	$61.91 - $67.42 $8,976 - $9,775	-145 Reduced 2.43%	5,814 $388,000
Q1 2021 May 13, 2021	BUY	$59.34 - $66.74 $80,761 - $90,833	1,361 Added 29.6%	5,959 $376,000
Q4 2020 Feb 26, 2021	BUY	$57.74 - $65.43 $253,940 - $287,761	4,398 Added 2199.0%	4,598 $285,000
Q4 2020 Feb 09, 2021	SELL	$57.74 - $65.43 $641,549 - $726,992	-11,111 Reduced 98.23%	200 $285,000
Q3 2020 Nov 13, 2020	BUY	$57.43 - $63.64 $629,375 - $697,430	10,959 Added 3113.35%	11,311 $682,000
Q2 2020 Aug 19, 2020	SELL	$54.82 - $64.09 $50,050 - $58,514	-913 Reduced 72.17%	352 $21,000
Q4 2019 Mar 03, 2020	BUY	$49.21 - $64.19 $62,250 - $81,200	1,265 New	1,265 $81,000

Others Institutions Holding BMY

# of Institutions

2,533

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $125B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rmr Wealth Builders, based on Form 13F filings with the SEC.

News

Stay updated on Rmr Wealth Builders with notifications on news.

Account

Rmr Wealth Builders Bristol Myers Squibb CO Transaction History